Explicit models make for better policy

Author： Grassly N.C.   Garnett G.P.  

Publisher： Elsevier

ISSN： 0955-3959

Source： The International Journal of Drug Policy, Vol.14, Iss.4, 2003-08, pp. : 339-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Better tools to inform health policy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 427, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Delivering Better Medicines to Children: Need for Better Integration Between the Science, the Policy, and the Practice

By Gazarian Madlen  

Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. : 41-44

Adis International

Access to resources Recommend Favorite

How can we (and why should we) develop better models of recovery?

By Leighton Tim  

Addiction Research and Theory, Vol. 15, Iss. 5, 2007-07 ,pp. : 435-438

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Models of Multiple Sclerosis: Advantages and Limitations Towards Better Therapies

By  

Current Medicinal Chemistry, Vol. 23, Iss. 14, 2016-04 ,pp. : 1442-1459

Bentham Science Publishers

Access to resources Recommend Favorite

Explicit reformulations of the Lambert W -omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis-Menten elimination kinetics

By Goličnik Marko  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 36, Iss. 3, 2011-09 ,pp. : 121-127

Springer Publishing Company

Access to resources Recommend Favorite